Association of β-Amyloid Burden With Sleep Dysfunction and Cognitive Impairment in Elderly Individuals With Cognitive Disorders

Published on Oct 2, 2019
· DOI :10.1001/JAMANETWORKOPEN.2019.13383
Jason C. You5
Estimated H-index: 5
(Thomas Jefferson University),
Erica Jones1
Estimated H-index: 1
(Thomas Jefferson University Hospital)
+ 4 AuthorsCarol F. Lippa50
Estimated H-index: 50
(Thomas Jefferson University Hospital)
Sources
Abstract
Importance Evidence shows that sleep dysfunction and β-amyloid (Aβ) deposition work synergistically to impair brain function in individuals with normal cognition, increasing the risk of developing dementia later in life. However, whether Aβ continues to play an integral role in sleep dysfunction after the onset of cognitive decline in individuals with dementia is unclear. Objective To determine whether Aβ deposition in the brain is associated with subjective measures of sleep quality and cognition in elderly individuals with cognitive disorders. Design, Setting, and Participants A nested survey study was conducted at the Cognitive Disorders and Comprehensive Alzheimer Disease Center of Thomas Jefferson University Hospital in Philadelphia, Pennsylvania. Participants included patients aged 65 years and older with cognitive disorders verified by neuropsychological testing. Eligible participants were identified from a referral center–based sample of patients who underwent fluorine 18–labeled florbetaben positron emission tomography imaging at Thomas Jefferson University Hospital as part of the multicenter Imaging Dementia-Evidence for Amyloid Scanning study. Data collection and analysis occurred between November 2018 and March 2019. Main Outcomes and Measures Sleep quality was measured via responses to sleep questionnaires, Aβ deposition was measured via fluorine 18–labeled florbetaben positron emission tomography, and cognition was measured via Mini-Mental State Examination (MMSE) performance. Results Of the 67 eligible participants, 52 (77.6%) gave informed consent to participate in the study. Of the 52 enrolled participants (mean [SD] age, 76.6 [7.4] years), 27 (51.9%) were women. Daytime sleepiness was associated with Aβ deposition in the brainstem (B = 0.0063; 95% CI, 0.001 to 0.012;P = .02), but not MMSE performance (B = −0.01; 95% CI, −0.39 to 0.37;P = .96). The number of nocturnal awakenings was associated with Aβ deposition in the precuneus (B = 0.11; 95% CI, 0.06 to 0.17;P  Conclusions and Relevance Nighttime sleep disruption may mediate the association between Aβ and cognitive impairment, suggesting that there is an underlying sleep-dependent mechanism that links Aβ burden in the brain to cognitive decline. Further elucidation of this mechanism may improve understanding of disease processes associated with Aβ accumulation.
📖 Papers frequently viewed together
2020
151 Citations
20134.80Sleep
79 Citations
References44
Newest
#1Brendan P. Lucey (WashU: Washington University in St. Louis)H-Index: 16
#2Austin A. McCullough (WashU: Washington University in St. Louis)H-Index: 4
Last. David M. Holtzman (WashU: Washington University in St. Louis)H-Index: 180
view all 12 authors...
In Alzheimer’s disease (AD), deposition of insoluble amyloid-β (Aβ) is followed by intracellular aggregation of tau in the neocortex and subsequent neuronal cell loss, synaptic loss, brain atrophy, and cognitive impairment. By the time even the earliest clinical symptoms are detectable, Aβ accumulation is close to reaching its peak and neocortical tau pathology is frequently already present. The period in which AD pathology is accumulating in the absence of cognitive symptoms represents a clinic...
84 CitationsSource
#1Kristine A. Wilckens (University of Pittsburgh)H-Index: 11
#2Dana L. Tudorascu (University of Pittsburgh)H-Index: 21
Last. Ann D. Cohen (University of Pittsburgh)H-Index: 29
view all 14 authors...
Abstract Amyloid-β (Aβ) accumulation is a hallmark of Alzheimer's disease, although Aβ alone may be insufficient to cause impairments. Modifiable health factors, including sleep, may mitigate functional symptoms of neurodegeneration. We assessed whether sleep moderated the relationship between Aβ and cognitive performance in 41 older adults, mean age 83 years. Sleep measures included actigraphy-assessed wake after sleep onset and total sleep time. Cognitive performance was assessed with memory r...
14 CitationsSource
#1Diego Z. Carvalho (Mayo Clinic)H-Index: 9
#2Erik K. St. Louis (Mayo Clinic)H-Index: 30
Last. Prashanthi Vemuri (Mayo Clinic)H-Index: 74
view all 12 authors...
Importance Aging is associated with excessive daytime sleepiness (EDS), which has been linked to cognitive decline in the elderly. However, whether EDS is associated with the pathologic processes of Alzheimer disease remains unclear. Objective To investigate whether EDS at baseline is associated with a longitudinal increase in regional β-amyloid (Aβ) accumulation in a cohort of elderly individuals without dementia. Design, Setting, and Participants This prospective analysis included participants...
65 CitationsSource
#1Darina V. Petrovsky (UPenn: University of Pennsylvania)H-Index: 4
#2Miranda V. McPhillips (UPenn: University of Pennsylvania)H-Index: 2
Last. Nancy A. Hodgson (UPenn: University of Pennsylvania)H-Index: 24
view all 6 authors...
Abstract Sleep disruption in persons with dementia is pervasive and contributes to negative health outcomes and decreased quality of life. Using Lawton's framework for quality of life in persons with dementia, the aim of this state-of-the-art review was to synthesize current knowledge on the association between sleep disruption and quality of life in persons with dementia in four domains: physical, social/behavioral, emotional well-being, and cognitive. Based on the final sample of six studies, ...
7 CitationsSource
#1William M. Vanderheyden (Washington State University Spokane)H-Index: 11
#1William M. Vanderheyden (Washington State University Spokane)H-Index: 3
Last. Jason R. Gerstner (Washington State University Spokane)H-Index: 17
view all 4 authors...
Sleep–wake abnormalities are common in patients with Alzheimer9s disease, and can be a major reason for institutionalization. However, an emerging concept is that these sleep–wake disturbances are part of the causal pathway accelerating the neurodegenerative process. Recently, new findings have provided intriguing evidence for a positive feedback loop between sleep–wake dysfunction and β-amyloid (Aβ) aggregation. Studies in both humans and animal models have shown that extended periods of wakefu...
20 CitationsSource
#1Teruyuki Matsuoka (Kyoto Prefectural University of Medicine)H-Index: 11
#2Ayu Imai (Kyoto Prefectural University of Medicine)H-Index: 4
Last. Jin Narumoto (Kyoto Prefectural University of Medicine)H-Index: 25
view all 9 authors...
BACKGROUND: Sleep disturbance may affect the development of Alzheimer's disease (AD), but the neural correlates of sleep disturbance in AD have not been fully clarified. OBJECTIVE: To examine the factors associated with sleep disturbance in AD. METHODS: A retrospective study was performed in 63 patients with AD. None of the patients had been prescribed antidementia or psychoactive drugs, and all underwent brain magnetic resonance imaging (MRI) before medication. Sleep disturbance was defined as ...
5 CitationsSource
#1Brendan P. Lucey (WashU: Washington University in St. Louis)H-Index: 16
#2Terry J. Hicks (WashU: Washington University in St. Louis)H-Index: 2
Last. Randall J. Bateman (WashU: Washington University in St. Louis)H-Index: 61
view all 12 authors...
: Sleep disturbances are associated with future risk of Alzheimer disease. Disrupted sleep increases soluble amyloid β, suggesting a mechanism for sleep disturbances to increase Alzheimer disease risk. We tested this response in humans using indwelling lumbar catheters to serially sample cerebrospinal fluid while participants were sleep-deprived, treated with sodium oxybate, or allowed to sleep normally. All participants were infused with 13 C6 -leucine to measure amyloid β kinetics. We found th...
108 CitationsSource
#1Michel J. Grothe (German Center for Neurodegenerative Diseases)H-Index: 33
#2Henryk Barthel (Leipzig University)H-Index: 56
Last. Stefan J. Teipel (German Center for Neurodegenerative Diseases)H-Index: 65
view all 6 authors...
Objectives: To estimate a regional progression pattern of amyloid deposition from cross-sectional amyloid-sensitive PET data and evaluate its potential for in vivo staging of an individual9s amyloid pathology. Methods: Multiregional analysis of florbetapir ( 18 F-AV45)–PET data was used to determine individual amyloid distribution profiles in a sample of 667 participants from the Alzheimer9s Disease Neuroimaging Initiative cohort, including cognitively normal older individuals (CN) as well as pa...
145 CitationsSource
#1Ram A. Sharma (NYU: New York University)H-Index: 4
#2Andrew W Varga (ISMMS: Icahn School of Medicine at Mount Sinai)H-Index: 9
Last. Ricardo S. Osorio (NYU: New York University)H-Index: 28
view all 32 authors...
Rationale: Recent evidence suggests that obstructive sleep apnea (OSA) may be a risk factor for developing mild cognitive impairment and Alzheimer’s disease. However, how sleep apnea affects longit...
79 CitationsSource
#1Andrew F. Hayes (OSU: Ohio State University)H-Index: 56
#2Nicholas J. Rockwood (OSU: Ohio State University)H-Index: 5
There have been numerous treatments in the clinical research literature about various design, analysis, and interpretation considerations when testing hypotheses about mechanisms and contingencies of effects, popularly known as mediation and moderation analysis. In this paper we address the practice of mediation and moderation analysis using linear regression in the pages of Behaviour Research and Therapy and offer some observations and recommendations, debunk some popular myths, describe some n...
564 CitationsSource
Cited By3
Newest
An aging-related reduction in the brain’s functional reserve may explain why delirium is more frequent in the elderly than in younger people insofar as the reserve becomes inadequate to cover the metabolic requirements that are critically increased by stressors. The aim of this paper is to review the normal aging-related changes that theoretically compromise complex mental activities, neuronal and synaptic densities, and the neurocomputational flexibility of the functional reserve. A pivotal fac...
Source
#1Clark Gt (RPI: Rensselaer Polytechnic Institute)
#2Yanlei Yu (RPI: Rensselaer Polytechnic Institute)H-Index: 11
Last. Jennifer M. Hurley (RPI: Rensselaer Polytechnic Institute)H-Index: 14
view all 8 authors...
Alzheimer's Disease (AD) is a neuroinflammatory disease characterized partly by the inability to clear, and subsequent build-up, of amyloid-beta (A{beta}). A{beta} clearance is regulated by several pathways and has a circadian component. However, the mechanism underlying the circadian clearance of A{beta} has not been defined. Myeloid-based phagocytosis, a key mechanism in the metabolism of A{beta}, is circadianly-regulated, presenting a potential mechanism for the circadian clearance of A{beta}...
Source
#1Kai ZhangH-Index: 6
#2Hiroshi Mizuma (IPMU: Institute for the Physics and Mathematics of the Universe)H-Index: 1
Last. Yasuyoshi WatanabeH-Index: 58
view all 14 authors...
Normal brain aging is commonly associated with neural activity alteration, β-amyloid (Aβ) deposition, and tau aggregation, driving a progressive cognitive decline in normal elderly individuals. Positron emission tomography (PET) with radiotracers targeting these age-related changes has been increasingly employed to clarify the sequence of their occurrence and the evolution of clinically cognitive deficits. Herein, we reviewed recent literature on PET-based imaging of normal human brain aging in ...
1 CitationsSource
#1Jeremy A. Elman (UCSD: University of California, San Diego)H-Index: 15
#2Olivia K. Puckett (UCSD: University of California, San Diego)H-Index: 1
Last. William S. Kremen (UCSD: University of California, San Diego)H-Index: 70
view all 30 authors...
INTRODUCTION The locus coeruleus (LC) undergoes extensive neurodegeneration in early Alzheimer's disease (AD). The LC is implicated in regulating the sleep-wake cycle, modulating cognitive function, and AD progression. METHODS Participants were 481 men (ages 62 to 71.7) from the Vietnam Era Twin Study of Aging. LC structural integrity was indexed by neuromelanin-sensitive magnetic resonance imaging (MRI) contrast-to-noise ratio (LCCNR ). We examined LCCNR , cognition, amnestic mild cognitive imp...
Source
#1Victoria M. Pak (Emory University)H-Index: 11
#1Victoria M. Pak (Emory University)H-Index: 1
Last. Fannie OnenH-Index: 10
view all 6 authors...
Mild cognitive impairment (MCI) and Alzheimer’s disease (AD) affect a high proportion of the elderly population with increasing prevalence. Sleep disturbances are frequent in those with MCI and AD. This review summarizes existing research on sleep disturbances and neuroinflammation in MCI and AD. Although strong evidence supports various pathways linking sleep and AD pathology, the temporal direction of this central relationship is not yet known. Improved understanding of sleep disturbance and n...
Source
Symptomatic interventions for patients with dementia involve anti-dementia drugs to improve cognition, psychotropic drugs for the treatment of behavioral disorders (BDs), and different categories of drugs for concomitant disorders. Demented patients may take >6–10 drugs/day with the consequent risk for drug–drug interactions and adverse drug reactions (ADRs >80%) which accelerate cognitive decline. The pharmacoepigenetic machinery is integrated by pathogenic, mechanistic, metabolic, transporter,...
16 CitationsSource
#1Christian Brachem (University of Bonn)H-Index: 1
#2Angela Winkler (University of Duisburg-Essen)H-Index: 9
Last. Martha Jokisch (University of Duisburg-Essen)H-Index: 5
view all 11 authors...
Associations of sleep characteristics with mild cognitive impairment (MCI) have been examined in cross-sectional, but rarely in longitudinal studies. Incident MCI and sleep characteristics were assessed in 1,890 participants of the first and second follow-up of the Heinz Nixdorf Recall study, a population-based cohort study in Germany (age at first follow-up 50−80 years, mean follow-up 5.2 years). MCI was assessed with extensive cognitive tests. Sleep questionnaires including PSQI (Pittsburgh Sl...
Source